China Healthcare_ Time to buy leading China CXOs_ Top picks WuXi AppTec & WuXi Bio
Applause·2024-11-22 16:18
18 Nov 2024 20:06:24 ET │ 21 pages China Healthcare Time to buy leading China CXOs: Top picks WuXi AppTec & WuXi Bio CITI'S TAKE We believe that the highly anticipated potential YE24 legislation of the Biosecure Act should limit further downside to China CXO sector. As a result, we see now as the time to buy given: 1) LO investors may build new positions structurally when the legislation is finalized; and 2) contract liability and latest contract trends may imply a potential guidance lift in the next few mo ...